Miltenyi Biotec Opens a New Office in South Korea

AsiaNet 53530

BERGISCH GLADBACH, Germany, June 27, 2013 /PRN=KYODO JBN/--

     Miltenyi Biotec, the world's leading cell innovation company, announced

today that it opened a new office in Seoul, Korea, enlarging the company's

Asia-Pacific presence to six locations in five countries.

    "Miltenyi Biotec recognizes the potential of a Korean presence in achieving

strong, steady growth and expanding our global reach with a team of talented

people," said CEO Boris Stoffel. "Our new team has an exceptional ability to

partner with scientists and clinicians to generate exciting opportunities."

    Daesuk Oh has been appointed General Manager of the new office in the

Gangnam district of Seoul. "Our location will be instrumental in developing

deeper relationships with a host of stem cell, immunology, translational

research, and clinical customers, as well as prospective research and clinical

institutions throughout South Korea. We're excited for the opportunity to bring

Miltenyi Biotec's solutions to scientists and clinicians who can truly benefit

from the quality and reliability the portfolio is known for," said Oh.

    About Miltenyi Biotec

    Miltenyi Biotec is a global provider of products and services that advance

biomedical research. From research tools to GMP reagents, Miltenyi is making

the promise of cell therapy a reality. The company's integrated portfolio of

tools supports the translation of basic research into practical applications

for human health. Scientists and clinicians around the world use

Miltenyi-enabling technologies for effective sample preparation, cell

isolation, flow cytometry, cell culture, molecular analysis and preclinical

imaging. The MACS(R) brand has set standards in the industry and is trusted

across basic, translational, and clinical research settings. The company also

offers comprehensive technical support and training through its MACS(R)

Academy. Miltenyi Biotec has 1,400 employees in 22 countries.

    Media Contact:

    Prof. Dr. Uwe Heinlein

    Phone: +49-2204-8306-6590

    E-mail: press@miltenyibiotec.de

    http://www.miltenyibiotec.com

    SOURCE: Miltenyi Biotec GmbH